DRUG PRODUCTION AND ITS REGULATORY REQUIREMENTS: EXPANDING THE SCOPE OF PHARMACEUTICAL SAFETY AND INNOVATION

Аннотация
This expanded article delves deeply into the pharmaceutical manufacturing process, examining the global and national regulations, quality assurance mechanisms, clinical and post-marketing evaluations, and the environmental and ethical implications of drug production. It explores the growing role of digital innovations such as AI and bioinformatics in the sector and emphasizes Uzbekistan’s achievements and challenges. A comparative analysis of international best practices is also provided, aimed at informing policy reforms and fostering sustainable pharmaceutical development.
Ключевые слова
Pharmaceutical industry, GMP, GxP, AI in pharma, drug safety, pharmacovigilance, clinical trials, eco-pharma, regulatory harmonization, Uzbekistan healthcare.
Библиографические ссылки
- D.A. Tursunova, X.T. Axmedova. Current issues and future directions in pharmacy: a scientific perspective. vol. 11 No. 2 (2025): International journal of scientific researchers
- https://worldlyjournals.com/index.php/IJSR/article/view/12093/16404
- World Health Organization. (2022). Substandard and falsified medical products.
- Ministry of Health of Uzbekistan. (2023). Pharmaceutical industry statistics.
- Kumar, R., Singh, J., & Verma, A. (2019). Journal of Pharmaceutical Research.
- McKinsey & Company. (2021). AI in pharma R&D.
- OECD/EUIPO. (2020). Trade in Counterfeit Pharmaceutical Products.
- European Medicines Agency. (2021). Environmental Risk Assessment.
- Legal Portal of Uzbekistan (Lex.uz). (2022). Regulation of drug circulation.
- BBC News. (2012). Pakistan Punjab drug scandal.
- WHO. (2023). Gambia cough syrup investigation.
- DeepMind AlphaFold. (2022). Protein structure database.